InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: None

Tuesday, 07/28/2020 2:35:18 PM

Tuesday, July 28, 2020 2:35:18 PM

Post# of 42881
The Humanigen/Remdesivir Pitfall

Humanigen's drug has quickly run through it's trials on account of it's lax standard in it's study criteria. As such it is now in a competition study against Remdesivir where it now faces two lethal pitfalls.

Pitfall 1: Death By Apples And Oranges

Remdesivir and Humanigen's questionable cocktail have both gone through their testing. However Remedsivir's inclusion and exclusion criteria are different from Humanigen. A comparison study done on Humanigen's terms will create an abnormal data set. Remdesivir had more rigorous testing. So having the same light standards as Humanigen will show greater efficacy then what physicians in the field are already seeing. This will raise questions about the legitimacy of the study.

If Humanigen runs under Remdesivir's standards, they will have to include patients they got to exclude under their cherry picking protocols. This means lower efficacy and safety results. As these excluded groups will likely report more adverse reactions.

If Humanigen is allowed to run under it's own cherry picked standards doing a comparison becomes a moot point. Comparing apples to oranges as it were.

Pitfall 2: Safety Results

Humanigen has not fully released all it's safety data, a search on google yielded only the infamous 12 person study. 12 cherry picked patients none of them on oxygen yet declared to be in the severe category:
https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v2

So in the competition study more results are to come. If they are on par with or only slightly better than Remdesivir then Humanigen is dead in the water.

Why you ask?

Because another drug has already show itself to be 63% safer. So even if Humanigen breezes by on its lax testing standards it still can't escape it's safety profile. Unless it has a stellar moonshot safety profile they run into another Chagas fiasco and no drug:

https://www.nature.com/articles/nbt1117-1003.pdf?origin=ppub

Do your due diligence, don't get caught in the pump and dump.